COVID-19 China vaccine candidate update via Reuters:
- Sinovac's covid-19 vaccine appeared to be safe and well-tolerated at all tested doses - phase i/ii trial results
- findings from phase iii will be crucial to determine Coronavac's immune response - study
- Sinovac's vaccine Coronavac suitable for emergency use during the pandemic, researchers say
- antibody levels induced by the coronavac vaccine were lower than those seen in people who had recovered from covid-19 - study
more to come
